University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

David G. Hwang, M.D.


Dr. David G. Hwang, director of the Cornea and Refractive Surgery Service at UCSF Medical Center, is an expert in cornea, cataract and laser refractive surgery. At UCSF, he has led a number of important Food and Drug Administration (FDA) monitored clinical trials studying LASIK and other refractive procedures, including one of the first U.S. clinical trials studying the excimer laser to correct refractive eye conditions. Hwang also has authored a number of texts and scientific articles on refractive surgery.

Hwang earned a medical degree at UCSF, graduating first in his medical school class. He completed two years of internal medicine residency and three years of ophthalmology residency at UCSF. He obtained concurrent fellowship training in uveitis and external disease as well as in cornea and laser refractive surgery at the University of Southern California's Doheny Eye Institute in Los Angeles. In 1990, Hwang joined the UCSF faculty, where he is a professor in ophthalmology.


Corneal Disease and Surgery
8 Koret Way, Suite U-545
San Francisco, CA 94143
Phone: (415) 514-8200
Fax: (415) 514-6195

Laser Vision Center
8 Koret Way, Room U-519
San Francisco, CA 94143–0644
Phone: (415) 353–2020
Fax: (415) 514–6904

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

More about David G. Hwang


UCSF 1984


UCSF, Ophthalmology 1989

Selected Research and Publications

  1. Seider MI, Hwang DG, Damato BE. Peculiar protuberance. JAMA Ophthalmol. 2014 Dec 1; 132(12):1483-4.
  2. Fintelmann RE, Kim SK, Hwang DG. Upside-down lens syndrome: ocular complications secondary to inverted implantation of the Kelman Multiflex anterior chamber intraocular lens. Am J Ophthalmol. 2011 Jul; 152(1):122-125.e2.
  3. Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. Am J Ophthalmol. 2010 Nov; 150(5):744-751.e2.
  4. Rutar T, Hwang DG, Stamper RL. Acute angle-closure glaucoma due to iris transfixation of a subluxated posterior chamber intraocular lens-capsular bag complex. J Cataract Refract Surg. 2007 Sep; 33(9):1662-3.
  5. Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol. 2006 Jul; 124(7):1051-3.
  6. Magone MT, Maric I, Hwang DG. Peripheral interstitial keratitis: a novel manifestation of ocular mastocytosis. Cornea. 2006 Apr; 25(3):364-7.
  7. Naseri A, Forseto AS, Francesconi CM, Hwang DG, Campos M, Nose W. Comparison of topographic corneal irregularity after LASIK and intrastromal corneal ring segments in the same patients. J Refract Surg. 2005 Nov-Dec; 21(6):722-6.
  8. Hsiao CH, Sah WJ, Soya K, Ma DH, Im YW, Zhang F, Hwang DG. Effects of SV40 T antigen transduction on human corneal endothelial cell wound healing in vitro. J Ocul Pharmacol Ther. 2005 Oct; 21(5):353-66.
  9. Sugioka K, Drake JD, Fukuda M, Shimomura Y, Hwang DG. Susceptibility of human corneal endothelial cells to HSV-1 infection. Curr Eye Res. 2005 Oct; 30(10):863-9.
  10. McLeod SD, Mather R, Hwang DG, Margolis TP. Uveitis-associated flap edema and lamellar interface fluid collection after LASIK. Am J Ophthalmol. 2005 Jun; 139(6):1137-9.
  11. Cheung MC, Nune GC, Hwang DG, Sutter EE, Duncan JL. Acute zonal occult outer retinopathy in a patient with graft-versus-host disease. Am J Ophthalmol. 2004 Dec; 138(6):1058-60.
  12. Kuo IC, Lee SM, Hwang DG. Late-onset corneal haze and myopic regression after photorefractive keratectomy (PRK). Cornea. 2004 May; 23(4):350-5.
  13. Jeng BH, Stewart JM, McLeod SD, Hwang DG. Relapsing diffuse lamellar keratitis after laser in situ keratomileusis associated with recurrent erosion syndrome. Arch Ophthalmol. 2004 Mar; 122(3):396-8.
  14. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004 Mar; 49 Suppl 2:S79-83.
  15. Aldave AJ, Yellore VS, Hwang DG. Atypical vortex pattern of corneal deposits in granular corneal dystrophy. Cornea. 2003 Nov; 22(8):754-9.
  16. McLeod SD, Tham VM, Phan ST, Hwang DG, Rizen M, Abbott RL. Bilateral diffuse lamellar keratitis following bilateral simultaneous versus sequential laser in situ keratomileusis. Br J Ophthalmol. 2003 Sep; 87(9):1086-7.
  17. Ma DH, Chen JI, Zhang F, Hwang DG, Chen JK. Inhibition of fibroblast-induced angiogenic phenotype of cultured endothelial cells by the overexpression of tissue inhibitor of metalloproteinase (TIMP)-3. J Biomed Sci. 2003 Sep-Oct; 10(5):526-34.
  18. Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Br J Ophthalmol. 2003 Aug; 87(8):1004-9.
  19. Ma DH, Zhang F, Shi W, Yao JY, Hsiao CH, Wu HC, Kim WS, Hao YX, Hwang DG, Chen JK, Tsai RJ. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res. 2003 Jul-Aug; 35(4):199-207.
  20. Iwata M, Soya K, Sawa M, Sakimoto T, Hwang DG. CD40 expression in normal human cornea and regulation of CD40 in cultured human corneal epithelial and stromal cells. Invest Ophthalmol Vis Sci. 2002 Feb; 43(2):348-57.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.